期刊文献+

组蛋白修饰与甲状腺癌

Histone modification and thyroid tumor
原文传递
导出
摘要 组蛋白修饰是表观遗传学的重要组成部分,其在甲状腺癌的诊断、治疗等方面的研究越来越多.甲基化、乙酰化、磷酸化及泛素化组蛋白修饰均可参与甲状腺癌的发生.组蛋白修饰可参与调控甲状腺癌细胞的分化,影响肿瘤细胞的增殖.组蛋白去乙酰化酶抑制剂可用于甲状腺癌的治疗. Histone modification is one of the major forms of epigenetic modifications,there are more and more researches on the applications of histone modifications in the diagnosis and treatment of thyroid tumor.Methylation,acetylation,phosphorylation and ubiquitin of histone modification involve in thyroid cancer.Histone modification can regulate the differentiation of thyroid cancer,influence the proliferation of tumor cells.Histone deacetylases may be used in the treatment of thyroid tumors.
出处 《国际内分泌代谢杂志》 北大核心 2014年第5期348-350,359,共4页 International Journal of Endocrinology and Metabolism
基金 基金项目:国家自然科学基金资助项目(81170759)
关键词 组蛋白修饰 甲状腺癌 表观遗传学 Histone modification Thyroid tumor Epigenetics
  • 相关文献

参考文献30

  • 1Kurdistani SK. Historic modifications in cancer biology and prog- nosis [ M ]. Epigenetics and Disease. Springer Basel, 2011 : 91- 106. 被引量:1
  • 2Dawson MA, Kouzarides T. Cancer epigenetics : from mechanism to therapy[ J]. Cell, 2012,150( 1 ) : 12-27. 被引量:1
  • 3Rasso D, Damante G, Puxeddu E, et al. Epigenetics of thyroid Cancer and novel therapeutic targets [ J ]. J Mol Endoerinol, 2011, 46(3) :R73-R81. 被引量:1
  • 4Weichert W, Roske A, Niesporek S, et al. Class I histone deacetylase expression has independent prognostic impact in hu- man colorectal cancer: specific role of class I histone deacety-lases in vitro and in vivo [ J]. Clin Cancer Res, 2008,14 (6): 1669-1677. 被引量:1
  • 5Seligson DB, Horvath S, Mcbrian MA, et al. Global levels of histone modifications predict prognosis in different cancers [ J ]. Am J Pathol, 2009,174(5) :1619-1628. 被引量:1
  • 6Mosashvilli D, Kahl P, Mertens C, et al. Global histone acetyla- tion levels: prognostic relevance in patients with renal cell carci- noma[ J]. Cancer Sci, 2010,101 (12) :2664-2669. 被引量:1
  • 7Puppin C, Passon N, Lavarone E, et al. Levels of histone acety- lation in thyroid tumors [ J ]. Biochem Biophys Res Commun, 2011,411 (4) :679-683. 被引量:1
  • 8Poke FS, Qadi A, Holloway AF. Reversing aberrant methylation patterns in Cancer[ J ]. Curr Med Chem, 2010,17 ( 13 ) : 1246- 1254. 被引量:1
  • 9Kondo T, Nakazawa T, Ma D, et al. Epigenetic silencing of TrF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas [ J ]. Lab Invest, 2009,89 ( 7 ) : 791-799. 被引量:1
  • 10Lavarone E, Puppin C, Passon N, et al. The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid Cancer cell lines[ J]. Mol Cell Endocrinol, 2013,365 (1) :1-10. 被引量:1

二级参考文献33

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部